Application of Lactobacillus plantarum LZ015, its freeze-dried powder and postbiotics in removing chloasma
By developing LZ015, Lycodonidae and its lyophilized powder and epibiotics, it significantly inhibits tyrosinase, improves SOD vitality, and reduces the content of malondialdehyde and TYR, and solves the low whitening and freckle removal effect of microbial metabolites in the prior art. The problem has achieved significant elimination or fading of melasma.
Patent Information
- Application Number
- CN202411336531.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-25
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-25
AI Technical Summary
In the prior art, microbial metabolites have low whitening and freckle removal effects in whitening or freckle removal products, and usually require combined effects with other chemical components, making it difficult to significantly subside or fade chloasma.
A product with significantly inhibiting tyrosinase activity was developed by developing a plant-based LZ015, its lyophilized powder and epibiotics. Through fermentation culture and lyophilization treatment, a product with significant inhibition of tyrosinase activity was prepared, thereby significantly improving SOD vitality in the skin and reducing C. The content of dialdehyde and TYR achieves the effect of eliminating or fading chloasma.
Lyrodized powder or epibiotics of LZ015 plantarum significantly inhibits tyrosinase, improves SOD vitality, reduces the content of malondialdehyde and TYR, and has a significant effect of regressing or fading chloasma.
Smart Images

Figure CN118879585B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microorganisms, and particularly relates to application of Lactobacillus plantarum LZ015 and freeze-dried powder thereof and postbiotics in removing chloasma. Background Art
[0002] Melasma is a common skin disease characterized by yellow-brown pigmentation on the exposed skin surface, mostly distributed in a symmetrical butterfly shape on the cheeks. The cause of melasma is still unclear, and there are many factors involved in its formation, among which genetic susceptibility (family genetic tendency), sun exposure (ultraviolet radiation causes activation of pigment cell function, long-term ultraviolet damage can damage the epidermal barrier, increase the release of inflammatory cytokines, stimulate the increase of tyrosinase activity in cells, and promote melanin synthesis and transport), and changes in sex hormone levels (estrogen can stimulate melanocytes to secrete melanin granules, and progesterone can promote the transport and diffusion of melanin granules) are important pathogenic factors. Disorders of melanin metabolism in the skin, impaired epidermal permeability barrier function, and local inflammatory reactions are the main mechanisms of melasma. Effective methods to relieve melasma usually include fruit acid treatment, laser wrinkle removal and freckle removal, topical vitamin E cream, etc.
[0003] As a microorganism that lives in the human intestine, probiotics are increasingly attracting widespread attention from researchers in this field due to their relative safety and diverse efficacy. At present, although there are reports in the prior art that fermented extracts of various fungi or bacteria can be added to whitening or freckle removal products, the whitening and freckle removal effects of these microbial metabolites themselves are not high, and usually require combined action with other chemical components. Therefore, continuing to screen probiotics with significant effects on fading or lightening chloasma and developing related preparations is the key to research in this field. Summary of the invention
[0004] In order to solve the problems existing in the prior art, the object of the present invention is to provide a Lactobacillus plantarum LZ015 and its freeze-dried powder and postbiotics, which have a significant effect of fading or lightening chloasma.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The present invention provides a plant lactobacillus ( Lactiplantibacillus plantarum ) LZ015, the preservation number of the plant lactobacillus LZ015 is CGMCC No: 29395.
[0007] The invention also provides a method for preparing the Lactobacillus plantarum LZ015 freeze-dried powder, comprising the following steps: fermenting and culturing the Lactobacillus plantarum LZ015, centrifuging the fermentation liquid, adding a freeze-drying protective agent to the precipitate, and freeze-drying to obtain the Lactobacillus plantarum LZ015 freeze-dried powder.
[0008] Preferably, in terms of mass percentage, the lyoprotectant comprises 8-12% skim milk, 7-9% trehalose, 4-6% sucrose, 5-7% maltodextrin, 1-3% mannose, 0.1-0.3% citric acid, 0.04-0.06% L-cysteine hydrochloride and 0.05-0.15% Tween 80.
[0009] The present invention also provides the Lactobacillus plantarum LZ015 freeze-dried powder prepared by the preparation method.
[0010] The present invention also provides a method for preparing Lactobacillus plantarum LZ015 postbiotics, comprising the following steps: inoculating the Lactobacillus plantarum LZ015 into kudzu root juice for fermentation and culturing, freeze-drying the kudzu root fermentation liquid, and obtaining the Lactobacillus plantarum LZ015 postbiotics.
[0011] Preferably, in terms of mass percentage, the Pueraria juice also contains 8-12% glucose, 0.05-0.15% dipotassium hydrogen phosphate, 0.005-0.015% magnesium sulfate and 0.01-0.03% sodium acetate.
[0012] Preferably, the pH value of the Pueraria juice is 6.5-7.
[0013] The present invention also provides a Lactobacillus plantarum LZ015 postbiotic prepared by the above preparation method.
[0014] The present invention also provides the use of the Lactobacillus plantarum LZ015 or the Lactobacillus plantarum LZ015 freeze-dried powder or the Lactobacillus plantarum LZ015 postbiotics in preparing a product for fading or lightening chloasma.
[0015] Compared with the prior art, the technical solution of the present invention has the following beneficial effects:
[0016] The present invention obtains a strain of Lactobacillus plantarum LZ015 for the first time, and further prepares freeze-dried powder or postbiotics of Lactobacillus plantarum LZ015. It is found that the obtained freeze-dried powder or postbiotics of Lactobacillus plantarum LZ015 has an inhibitory effect on tyrosinase, can significantly improve the activity of SOD in the skin, reduce the contents of malondialdehyde and TYR, and have a significant effect of fading or lightening chloasma. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 :The macroscopic morphology of various colonies in the plate during the screening process of Lactobacillus plantarum LZ015;
[0018] Figure 2 :The macroscopic morphology of Lactobacillus plantarum LZ015 colonies;
[0019] Figure 3: Microscopic morphology of Lactobacillus plantarum strain LZ015.
[0020] Lactobacillus plantarum LZ015, classified as Lactobacillus plantarum ( Lactiplantibacillus plantarum ), depository: General Microbiology Center of China Microorganism Culture Collection Administration (CGMCC for short), depository address: Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, deposit number: CGMCCNo: 29395, deposit date December 25, 2023. DETAILED DESCRIPTION
[0021] The present invention provides a plant lactobacillus ( Lactiplantibacillus plantarum ) LZ015, the Lactobacillus plantarum LZ015 has a preservation number of CGMCC No: 29395, and is isolated and purified from homemade yogurt in Wulanbutong, Inner Mongolia, and is identified as Lactiplantibacillus plantarum , and was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on December 25, 2023. The address of the depository is: Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0022] The invention also provides a method for preparing the Lactobacillus plantarum LZ015 freeze-dried powder, comprising the following steps: fermenting and culturing the Lactobacillus plantarum LZ015, centrifuging the fermentation liquid, adding a freeze-drying protective agent to the precipitate, and freeze-drying to obtain the Lactobacillus plantarum LZ015 freeze-dried powder.
[0023] Fermentation culture of the present invention is preferably adopted MRS liquid nutrient medium.As optional embodiment, the present invention is first inoculated in MRS liquid nutrient medium by plant lactobacillus LZ015 and activated, plant lactobacillus LZ015 after activation is inoculated in MRS liquid nutrient medium and carries out enlarged culture and fermentation culture, fermentation culture liquid is centrifuged, and supernatant is discarded to obtain thalline, for the preparation of plant lactobacillus LZ015 freeze-dried powder.Activation of the present invention is preferably two-step activation, and the inoculum size of enlarged culture and fermentation culture of the present invention is preferably 1~4(v / v)%, more preferably 2~3(v / v)%.
[0024] The fermentation culture temperature of Lactobacillus plantarum LZ015 of the present invention is 36-38°C, preferably 37°C. The present invention preferably ferments and cultures until OD 600 The culture is terminated when the value is 14~15 and the pH is 3.75~3.80.
[0025] The centrifugal speed of the present invention is 7000-9000 rpm, preferably 8000 rpm, and the centrifugal time is 15-25 min, preferably 20 min.
[0026] The freeze-drying protective agent of the present invention (by mass percentage) includes 8-12% skim milk, 7-9% trehalose, 4-6% sucrose, 5-7% maltodextrin, 1-3% mannose, 0.1-0.3% citric acid, 0.04-0.06% L-cysteine hydrochloride and 0.05-0.15% Tween 80. Preferably, it includes 10% skim milk, 8% trehalose, 5% sucrose, 6% maltodextrin, 2% mannose, 0.2% citric acid, 0.05% L-cysteine hydrochloride and 0.1% Tween 80. The preparation method of the freeze-drying protective agent of the present invention comprises: adding water to skim milk, mixing, and sterilizing at high temperature; adding water to trehalose, sucrose, maltodextrin, mannose, citric acid, L-cysteine hydrochloride and Tween 80, mixing, and sterilizing at high temperature; mixing the two solutions when they are cooled to room temperature to form a freeze-drying protective agent.
[0027] The mass ratio of the bacterial cells to the lyophilization protective agent of the present invention is 1:1-3, preferably 1:2.
[0028] The freeze-drying method of the present invention is preferably: the bacteria and the freeze-drying protective agent are mixed and then placed in a cold trap at a temperature of -40°C for freeze drying for 45 to 50 hours, the freeze-dried bacterial powder is collected, crushed, and passed through a 60-100 mesh sieve to obtain the plant lactobacillus LZ015 freeze-dried powder. The freeze-drying time is preferably 48 hours, and the crushing is preferably passed through an 80 mesh sieve.
[0029] The present invention also provides a freeze-dried powder of Lactobacillus plantarum LZ015 prepared by the above method, wherein the live bacteria count of the freeze-dried powder of Lactobacillus plantarum LZ015 is carried out according to the GB4789.35 standard, and the live bacteria count is 1×10 11 ~9×10 11 cfu / g. 1L of fermentation liquid of the present invention can prepare 15g~30g of freeze-dried powder.
[0030] The present invention also provides a method for preparing a postbiotic of Lactobacillus plantarum LZ015, comprising the following steps: inoculating the above-mentioned Lactobacillus plantarum LZ015 into kudzu juice for fermentation and culture, and freeze-drying the kudzu fermentation liquid to obtain a postbiotic of Lactobacillus plantarum LZ015. As an optional embodiment, the present invention first inoculates Lactobacillus plantarum LZ015 into an MRS liquid culture medium for activation, inoculates the activated Lactobacillus plantarum LZ015 into an MRS liquid culture medium for expansion culture, and then inoculates Lactobacillus plantarum LZ015 seed liquid into kudzu juice for fermentation and culture, obtains kudzu fermentation liquid, and the kudzu fermentation liquid is freeze-dried after pasteurization to obtain a postbiotic of Lactobacillus plantarum LZ015. The activation of the present invention is preferably a two-step activation, and the inoculation amount of the expansion culture and fermentation culture of the present invention is preferably 1~4 (v / v)%, more preferably 2~3 (v / v)%.
[0031] The kudzu juice of the present invention (by mass percentage) also contains 8-12% glucose, 0.05-0.15% dipotassium hydrogen phosphate, 0.005-0.015% magnesium sulfate and 0.01-0.03% sodium acetate. Preferably, it contains 10% glucose, 0.1% dipotassium hydrogen phosphate, 0.01% magnesium sulfate and 0.02% sodium acetate. The pH value of the kudzu juice of the present invention is 6.5-7, and the pH value is preferably 6.8. As an optional embodiment, the preparation method of the kudzu juice of the present invention comprises: commercially available kudzu root is crushed and sieved, kudzu root powder and water are mixed in a mass ratio of 1:8-12 and then pulped, filtered and separated after steaming, and the filter residue is discarded to obtain kudzu juice. The kudzu juice of the present invention is preferably adjusted to pH using a 1 mol / L sodium bicarbonate solution. The kudzu juice of the present invention is preferably sterilized at 121°C.
[0032] The fermentation culture temperature of the Lactobacillus plantarum LZ015 in kudzu root juice is 36-38° C., preferably 37° C., and the fermentation culture time is 45-50 hours, preferably 48 hours.
[0033] The Pueraria lobata fermented liquid of the present invention is pasteurized at 75-85°C for 25-35 minutes, the temperature is preferably 80°C, and the time is preferably 20 minutes. The freeze-drying method is preferably freeze-drying at -40°C for 45-50 hours, collecting the freeze-dried product, crushing it, and passing it through a 60-100 mesh sieve to obtain the plant lactobacillus LZ015 postbiotics. The freeze-drying time is preferably 48 hours, and the crushing is preferably passed through an 80-mesh sieve.
[0034] The present invention also provides a postbiotic produced by the Lactobacillus plantarum LZ015 preparation method. 100 g to 140 g of postbiotics can be produced from 1 L of fermentation liquid.
[0035] The present invention also provides the use of the above Lactobacillus plantarum LZ015 or the above Lactobacillus plantarum LZ015 freeze-dried powder or the above Lactobacillus plantarum LZ015 postbiotics in preparing products for fading or lightening chloasma. The products of the present invention include medicines, health products, cosmetics, skin care products, and cleaning products.
[0036] The technical solutions in the present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0037] In the embodiment of the present invention, the MRS solid culture medium includes: 10.0 g / L peptone, 5.0 g / L beef extract powder, 4.0 g / L yeast extract powder, 20.0 g / L glucose, 5.0 g / L sodium acetate, 2.0 g / L dipotassium hydrogen phosphate, 2.0 g / L triammonium citrate, 0.05 g / L manganese sulfate, 0.2 g / L magnesium sulfate, 1.0 g / L Tween 80, and 15.0 g / L agar.
[0038] MRS liquid culture medium: peptone 10.0 g / L, beef extract powder 5.0 g / L, yeast extract powder 4.0 g / L, glucose 20.0 g / L, sodium acetate 5.0 g / L, dipotassium hydrogen phosphate 2.0 g / L, triammonium citrate 2.0 g / L, manganese sulfate 0.05 g / L, magnesium sulfate 0.2 g / L, Tween 80 1.0 g / L.
[0039] Preparation of Pueraria juice: 500 g of commercially available Pueraria root (purchased from Anguo Chinese medicinal materials market) without spots or insect infestations was selected, crushed by a grinder, and then sieved through a 100-mesh sieve to obtain Pueraria root powder, then the Pueraria root powder was mixed with water in a mass ratio of 1:10 and pulped, steamed for 0.5 h, cooled to room temperature, filtered and separated, and the filter residue was discarded to obtain Pueraria juice.
[0040] Preparation of Pueraria juice powder: The Pueraria juice obtained by steaming is freeze-dried (freeze-dried at -40°C for 45 hours, the freeze-dried product is collected, crushed, and passed through a 100-mesh sieve) to obtain Pueraria juice powder.
[0041] In the following embodiments, unless otherwise specified, all of them are conventional methods.
[0042] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0043] Example 1
[0044] Strain screening and identification:
[0045] The strain was isolated from homemade yogurt in Wulanbutong, Inner Mongolia, using MRS solid medium. 0.9% saline was used for gradient dilution, and the soaking liquid with different dilution gradients was inoculated into MRS solid medium containing 2wt% calcium carbonate by pouring method. After inverted culture at 37℃ for 48h, the plate was checked and calcium dissolution ring was found (the result is shown in Figure 1As shown). According to the colony characteristics of lactic acid bacteria, the corresponding single colonies were selected and cultured in MRS liquid medium at 37°C for 24 hours. All the cultured strains were subjected to Gram staining, catalase test, gelatin liquefaction test, oxidase test, indole test, and nitrate reduction test. The strains with positive Gram staining and negative catalase test, gelatin liquefaction test, oxidase test, indole test, and nitrate reduction test were selected. A total of 26 strains were screened and numbered 001, 002, 003, 004, 005...025, 026.
[0046] The 26 strains were inoculated on MRS plates and cultured at 37°C to obtain single colonies. Single colonies were picked and inoculated into 10 mL MRS broth and cultured at 37°C overnight. Then, they were inoculated into MRS broth at a 2% (volume fraction) inoculation amount and cultured for 48 h. The supernatant was centrifuged at 4°C and 13,000×g for 10 min and filtered with a 0.22 μm filter to obtain a sterile fermentation supernatant. The pH was adjusted to 6.5 with 2% NaOH to obtain a neutralized fermentation supernatant, which was then stored at 4°C for later use.
[0047] The tyrosinase activity was determined by the DOPA rate oxidation method using mushroom tyrosinase (purchased from Sigma). 2 mL of reaction mixture: 1.8 mL of 0.1 M pH 6.5 PBS solution, 0.1 mL of fermentation supernatant, and 0.1 mL of tyrosinase (80 U). Incubate at 37°C for 10 min, and add 1 mL of 0.15% DL-DOPA. At 2 min, 3 min, 4 min, 5 min, and 6 min, the absorbance A value (A) was measured at 475 nm using a 722 grating spectrophotometer. 475 ), with A475 increasing by 0.001 per minute as 1 enzyme activity unit. The PBS solution was used as the blank, and the reaction group without fermentation supernatant was used as the control group to measure the tyrosinase activity. The results are shown in Table 1.
[0048] Table 1 Effects of fermentation supernatants of various strains on tyrosinase activity ( ±s, A value)
[0049]
[0050] Note: Compared with the control group,*: P <0.05.
[0051] From Table 1, we can see that among the supernatants of 26 strains, only 007, 015, 019 and 022 had an inhibitory effect on tyrosinase, and the effect was significant ( P <0.05).
[0052] Further experiments were conducted on strains 007, 015, 019 and 022: 100g of kudzu root juice, 20g of glucose, and 880g of purified water were prepared into a culture medium, and the pH was adjusted to 6.8-7.0, and the culture medium was divided into 100g bottles, sterilized at 121℃ for 20min and then used. After activating two generations of strains 007, 015, 019 and 022 in MRS medium at 37℃, they were inoculated into sterilized medium at a volume fraction of 3%, and then incubated at 37℃ for 24h to detect the number of viable bacteria, pH and OD 600 The test results are shown in Table 2.
[0053] Table 2 Detection results of Pueraria fermentation by various strains
[0054]
[0055] As shown in Table 2, strains 007, 015, 019 and 022 showed different results when fermenting Pueraria juice. Among them, strains 007, 019 and 022 could not grow well in Pueraria juice, and some components in Pueraria inhibited the growth of strains; strain 015 could grow well in Pueraria juice, and the number of viable bacteria could reach 10 8 Therefore, strain 015 can ferment Pueraria juice very well.
[0056] Strain 015 was inoculated on MRS solid medium and cultured at 37°C for 48 h. The colonies were white, round, moist, opaque, and had neat edges. Figure 2 shown.
[0057] Take strain 015 and inoculate it in MRS liquid medium, culture it at 37℃ for 24h, observe and take pictures with ordinary optical microscope, and find that the bacteria are rod-shaped, arranged singly or in pairs, and are Gram-positive bacteria. Figure 3 shown.
[0058] The strain 015 was sent to Shanghai Biotech Co., Ltd. for 16SrDNA sequencing, and the result was identified as Lactobacillus plantarum ( Lactiplantibacillus plantarum ), named as Lactobacillus plantarum LZ015, and deposited in the General Microbiology Center of China Microbiological Culture Collection Administration with the deposit number CGMCC No.29395.
[0059] Example 2
[0060] Preparation of lyophilized powder of Lactobacillus plantarum LZ015:
[0061] (1) Activation: Lactobacillus plantarum LZ015 was inoculated into MRS liquid culture medium and cultured anaerobically at 37°C for 24 h. It was then inoculated into MRS liquid culture medium at 1% (v / v) and cultured anaerobically at 37°C for 24 h.
[0062] (2) Seed culture: The activated bacterial solution obtained in step (1) was inoculated into MRS liquid culture medium at a 3% (v / v) inoculation rate, and cultured at 37°C for 17 h to obtain Lactobacillus plantarum LZ015 seed solution. The viable bacterial count of the seed solution was measured to be 3.5×10 9 ~5.0×10 9 cfu / mL.
[0063] (3) Fermentation: Inoculate the seed solution into MRS medium at a rate of 3% (v / v) and ferment at 37°C until OD 600 When the value is 14.5 and the pH is 3.75-3.80, the culture is terminated to obtain the fermentation broth of Lactobacillus plantarum LZ015.
[0064] (4) Preparation of freeze-dried powder: At 4°C, the fermentation liquid was centrifuged at 8000 rpm for 20 min, and the supernatant was discarded to obtain the bacterial cells. At 4°C, the bacterial cells and the protective agent were mixed in a mass ratio of 1:2 and then placed in a cold trap at -40°C for freeze drying for 48 h. The freeze-dried bacterial powder was collected, crushed, and passed through an 80-mesh sieve to obtain the freeze-dried powder of Lactobacillus plantarum LZ015.
[0065] The protective agent contains 10% skim milk, 8% trehalose, 5% sucrose, 6% maltodextrin, 2% mannose, 0.2% citric acid, 0.05% L-cysteine hydrochloride and 0.1% Tween 80. Add 34g water to 10g skim milk and mix well, and sterilize at 80℃ for 30min; add 34.65g water to 8g trehalose, 5g sucrose, 6g maltodextrin, 2g mannose, 0.2g citric acid, 0.05g L-cysteine hydrochloride and 0.1g Tween 80 and mix well, sterilize at 121℃ for 20min, and mix the two solutions when they are cooled to room temperature to form a freeze-dried protective agent.
[0066] 20g of freeze-dried powder was prepared from 1L of fermentation liquid. According to GB 4789.35 standard, the viable count of Lactobacillus plantarum LZ015 was 5.6×10 11 cfu / g.
[0067] Example 3
[0068] Preparation of lyophilized powder of Lactobacillus plantarum LZ015:
[0069] (1) Activation: Same as Example 2.
[0070] (2) Seed culture: Same as Example 2.
[0071] (3) Fermentation: Same as Example 2.
[0072] (4) Preparation of freeze-dried powder: At 4°C, the fermentation liquid was centrifuged at 7000 rpm for 25 min, and the supernatant was discarded to obtain the bacterial cells. At 4°C, the bacterial cells and the protective agent were mixed in a 1:1 ratio and placed in a cold trap at -40°C for freeze drying for 50 h. The freeze-dried bacterial powder was collected, crushed, and passed through an 80-mesh sieve to obtain the freeze-dried powder of Lactobacillus plantarum LZ015.
[0073] The protective agent contains 8% skim milk, 9% trehalose, 6% sucrose, 5% maltodextrin, 3% mannose, 0.2% citric acid, 0.05% L-cysteine hydrochloride and 0.1% Tween 80. 8g skim milk is added to 34g water and mixed, and sterilized at 80℃ for 30min; 9g trehalose, 6g sucrose, 5g maltodextrin, 3g mannose, 0.2g citric acid, 0.05g L-cysteine hydrochloride and 0.1g Tween 80 are added to 34.65g water and mixed, and sterilized at 121℃ for 20min. When the two solutions are cooled to room temperature, they are mixed to form a freeze-dried protective agent.
[0074] 23g of freeze-dried powder was prepared from 1L of fermentation liquid. According to GB 4789.35 standard, the viable count of Lactobacillus plantarum LZ015 was 4.9×10 11 cfu / g.
[0075] Example 4
[0076] Preparation of lyophilized powder of Lactobacillus plantarum LZ015:
[0077] (1) Activation: Same as Example 2.
[0078] (2) Seed culture: Same as Example 2.
[0079] (3) Fermentation: Same as Example 2.
[0080] (4) Preparation of freeze-dried powder: At 4°C, the fermentation liquid was centrifuged at 9000 rpm for 15 min, and the supernatant was discarded to obtain the bacterial cells. At 4°C, the bacterial cells and the protective agent were mixed in a ratio of 1:3 and then placed in a cold trap at -40°C for freeze drying for 50 h. The freeze-dried bacterial powder was collected, crushed, and passed through an 80-mesh sieve to obtain the freeze-dried powder of Lactobacillus plantarum LZ015.
[0081] The protective agent contains 8% skim milk, 7% trehalose, 4% sucrose, 5% maltodextrin, 1% mannose, 0.1% citric acid, 0.04% L-cysteine hydrochloride and 0.05% Tween 80. 8g skim milk is added to 34g water and mixed, and sterilized at 80℃ for 30min; 7g trehalose, 4g sucrose, 5g maltodextrin, 1g mannose, 0.2g citric acid, 0.04g L-cysteine hydrochloride and 0.05g Tween 80 are added to 40.71g water and mixed, and sterilized at 121℃ for 20min. When the two solutions are cooled to room temperature, they are mixed to form a freeze-dried protective agent.
[0082] 16g of freeze-dried powder was prepared from 1L of fermentation liquid. According to GB 4789.35 standard, the viable count of Lactobacillus plantarum LZ015 was 7.8×10 11 cfu / g.
[0083] Example 5
[0084] Preparation of Lactobacillus plantarum LZ015 postbiotics:
[0085] (1) Activation: Same as Example 2.
[0086] (2) Seed culture: Same as Example 2.
[0087] (3) Fermentation: 10 wt% glucose, 0.1 wt% potassium dihydrogen phosphate, 0.01 wt% magnesium sulfate, and 0.02 wt% sodium acetate were added to 1 L of Pueraria juice, and the initial pH was adjusted to 6.8 with 1 mol / L sodium bicarbonate solution. After sterilization at 121 °C, 3% (v / v) Lactobacillus plantarum LZ015 was inoculated and cultured at 37 °C for 48 h.
[0088] (4) Preparation of postbiotics: The Pueraria lobata fermentation broth was pasteurized at 80°C for 30 min, and then freeze-dried (freeze-dried at -40°C for 45 h, the freeze-dried product was collected, crushed, and sieved through a 60-mesh sieve) to obtain Lactobacillus plantarum LZ015 postbiotics.
[0089] 1L of fermentation broth produced 110g of postbiotics.
[0090] Example 6
[0091] Preparation of Lactobacillus plantarum LZ015 postbiotics:
[0092] (1) Activation: Same as Example 2.
[0093] (2) Seed culture: Same as Example 2.
[0094] (3) Fermentation: 12 wt% glucose, 0.15 wt% potassium dihydrogen phosphate, 0.015 wt% magnesium sulfate and 0.03 wt% sodium acetate were added to 1 L of Pueraria juice, and the initial pH was adjusted to 6.5 with 1 mol / L sodium bicarbonate solution. After sterilization at 121 °C, 3% (v / v) Lactobacillus plantarum LZ015 was inoculated and cultured at 37 °C for 48 h.
[0095] (4) Preparation of postbiotics: The Pueraria lobata fermentation broth was pasteurized at 75°C for 35 min, and then freeze-dried (freeze-dried at -40°C for 50 h, the freeze-dried product was collected, crushed, and passed through a 100-mesh sieve) to obtain Lactobacillus plantarum LZ015 postbiotics.
[0096] 135 g of postbiotics were prepared from 1 L of fermentation broth.
[0097] Example 7
[0098] Preparation of Lactobacillus plantarum LZ015 postbiotics:
[0099] (1) Activation: Same as Example 2.
[0100] (2) Seed culture: Same as Example 2.
[0101] (3) Fermentation: 8 wt% glucose, 0.05 wt% potassium dihydrogen phosphate, 0.005 wt% magnesium sulfate and 0.01 wt% sodium acetate were added to 1 L of Pueraria juice, and the initial pH was adjusted to 7 with 1 mol / L sodium bicarbonate solution. After sterilization at 121 °C, 3% (v / v) Lactobacillus plantarum LZ015 was inoculated and cultured at 37 °C for 48 h.
[0102] (4) Preparation of postbiotics: The Pueraria lobata fermentation broth was pasteurized at 85°C for 25 min, and then freeze-dried (freeze-dried at -40°C for 48 h, the freeze-dried product was collected, crushed, and sieved through an 80-mesh sieve) to obtain Lactobacillus plantarum LZ015 postbiotics.
[0103] 93 g of postbiotics were prepared from 1 L of fermentation broth.
[0104] Test Example 1
[0105] The tyrosinase activity of the Lactobacillus plantarum LZ015 freeze-dried powder and the Lactobacillus plantarum LZ015 postbiotics prepared in Example 2 and Example 5 was measured respectively:
[0106] Take 1 gram each of Lactobacillus plantarum LZ015 freeze-dried powder, Pueraria lobata juice powder, and Lactobacillus plantarum LZ015 postbiotics, dissolve them in 9 mL of sterile purified water respectively, and set aside.
[0107] The tyrosinase activity was determined by the DOPA rate oxidation method using mushroom tyrosinase (purchased from Sigma). Reaction mixture 2 mL: 0.1 mL of plant lactobacillus LZ015 freeze-dried powder, kudzu root juice powder, and plant lactobacillus LZ015 postbiotic solution were taken, 1.8 mL of 0.1M pH 6.5 PBS solution and 0.1 mL of tyrosinase (80 U) were added. Incubate at 37°C for 10 min, add 1 mL of 0.15% DL-DOPA, and measure the absorbance A value (A) at 475 nm using a 722 grating spectrophotometer at 2 min, 3 min, 4 min, 5 min, and 6 min, respectively. 475 ), with A 475 0.001 increase per minute is 1 enzyme activity unit. Using PBS solution as blank and the reaction group without fermentation supernatant as control, the tyrosinase activity was measured respectively. The results are shown in Table 3.
[0108] Table 3 Effects of each group on tyrosinase activity
[0109]
[0110] Note: Compared with the control group,*: P <0.05.
[0111] As shown in Table 3, compared with the control, the freeze-dried powder of Lactobacillus plantarum LZ015, the kudzu root juice powder, and the postbiotics of Lactobacillus plantarum LZ015 had an inhibitory effect on tyrosinase, and the effect was significant ( P <0.05); the postbiotic effect of Pueraria juice fermented by Lactobacillus plantarum LZ015 was better than that of freeze-dried powder of Lactobacillus plantarum LZ015 and Pueraria juice powder, but the difference was not significant.
[0112] Test Example 2
[0113] Animal experiments were conducted using the Lactobacillus plantarum LZ015 freeze-dried powder and the Lactobacillus plantarum LZ015 postbiotics prepared in Example 2 and Example 5, respectively:
[0114] 120 2-month-old female Kunming mice were selected. Except for 10 mice in the control group without modeling, the remaining 110 mice were randomly divided into 11 groups. The backs of all 11 groups of mice were shaved to fully expose the skin. The shaved area was 4 cm × 3 cm. The hair was shaved once a week, and 0.4% progesterone was injected intramuscularly at a dose of 0.02 g / kg, once a day, and the two hind limbs were injected alternately. Medium-wave ultraviolet rays (UY / B) with a wavelength of 275-320 nm were selected, and the skin was locally irradiated once a day, each time for 60 minutes. The distance between the mouse skin and the light source was 20 cm, and the model was established for 40 consecutive days. At the same time as the modeling, the 11 groups of mice were fed with the corresponding doses of drugs (as shown in Table 4), once a day in the afternoon, for 40 consecutive days.
[0115] Table 4 Dosage table for mice
[0116]
[0117] 2 hours after the last administration, the skin of the ultraviolet irradiated area on the back of the mouse was taken for the following tests:
[0118] (1) Take 100 mg of skin tissue, cut it into pieces and put it into a homogenizer. Add 0.9 mL of pre-cooled saline and make a homogenate in ice water. Centrifuge at 3000 r / min for 10 min. Take the supernatant and measure the SOD activity according to the method indicated in the SOD kit manual.
[0119] (2) Take 100 mg of skin tissue, cut it into pieces, add 0.9 mL of pre-cooled saline, make a homogenate in ice water, and determine the MDA content according to the method indicated in the MDA kit instructions.
[0120] (3) Take 100 mg of skin tissue, cut it into pieces, add 0.9 mL of pre-cooled saline, and make a homogenate in ice water. Determine the tyrosinase content according to the method indicated in the tyrosinase (TYR) kit instructions.
[0121] Table 5 Experimental results of whitening and removing chloasma in mice in each group
[0122]
[0123] Note: Compared with the model group, * P <0.05.
[0124] The results showed that compared with the blank group, the SOD activity in the skin of mice in the model group was significantly reduced ( P <0.05), the contents of MDA and TYR increased significantly ( P <0.05). This indicates that the chloasma mouse model was successfully prepared by the method of progesterone injection combined with ultraviolet irradiation. Compared with the model group, the low, medium and high dose groups of Lactobacillus plantarum LZ015 freeze-dried powder, kudzu root juice powder and Lactobacillus plantarum LZ015 postbiotics significantly increased the activity of SOD in the skin ( P <0.05), and significantly reduced the content of MDA and TYR ( P <0.05). Among them, the postbiotics prepared by fermenting Pueraria root with Lactobacillus plantarum LZ015 had the best effect in terms of SOD activity, TYR content, and malondialdehyde content, followed by the freeze-dried powder group of Lactobacillus plantarum LZ015, and the effect of Pueraria root juice powder group was poor, but the difference was significant compared with the model group ( P <0.05), indicating that Pueraria root has the effect of alleviating chloasma, and fermentation of Pueraria root with Lactobacillus plantarum LZ015 has a good therapeutic effect on chloasma model mice.
[0125] Test Example 3
[0126] The Lactobacillus plantarum LZ015 freeze-dried powder and the Lactobacillus plantarum LZ015 postbiotics prepared in Example 2 and Example 5 were respectively used to conduct a human trial experiment:
[0127] Diagnostic criteria: refer to the "Clinical Diagnosis and Efficacy Criteria for Chloasma" (revised in 2003) formulated by the Pigment Disease Group of the Dermatology and Venereology Committee of the National Association of Integrated Traditional Chinese and Western Medicine.
[0128] Inclusion criteria: All patients met the diagnostic criteria for chloasma, had no mental or consciousness diseases, could communicate effectively, had high treatment cooperation and compliance, and voluntarily signed the informed consent.
[0129] Exclusion criteria: patients with other facial diseases; patients with a history of allergic reactions to related drugs; patients with severe liver and kidney dysfunction; patients with other serious internal and external diseases; and patients who are pregnant or breastfeeding.
[0130] This trial accepted 114 patients with chloasma and post-inflammatory pigmentation spots for whitening and freckle removal as research subjects. They were randomly divided into Lactobacillus plantarum LZ015 freeze-dried powder group and Lactobacillus plantarum LZ015 postbiotic group, with 57 cases in the Lactobacillus plantarum LZ015 freeze-dried powder group and 57 cases in the Lactobacillus plantarum LZ05 postbiotic group. There was no statistical difference in the gender, age, disease type, severity, and course of disease between the two groups of volunteers selected for this study after statistical analysis ( P >0.05), which is comparable.
[0131] Experimental plan: The Lactobacillus plantarum LZ015 freeze-dried powder group consumed 3 grams of Lactobacillus plantarum LZ015 freeze-dried powder (20 billion / g), 3 times a day, half an hour after each meal; the Lactobacillus plantarum LZ015 postbiotics group consumed 3 grams of Lactobacillus plantarum LZ015 postbiotics, 3 times a day, half an hour after each meal. One month is one course of treatment, and 3 courses are taken continuously. The therapeutic effect is observed immediately after consuming 3 courses of treatment, and the therapeutic effects of the two groups of patients are compared.
[0132] During the treatment, the two groups of patients were advised to keep moisturized and avoid sun exposure, get enough sleep, and stay in a good mood. All patients were advised to abstain from alcohol during the treatment, eat more vegetables, fruits, and foods rich in trace elements, eat less spicy foods, and avoid sun exposure.
[0133] Efficacy criteria: divided into four levels: cured, markedly effective, improved, and ineffective. Cured: The color basically fades, the spots completely disappear or the faded area is ≥90%. Markedly effective: The color becomes significantly lighter, and the faded area of the spots is 60-89%. Improved: The color becomes lighter, and the faded area of the spots is 30-59%. Ineffective: Does not meet the above criteria. Total effective rate = (cured + markedly effective + improved) cases / total cases × 100%.
[0134] Melasma Area and Severity (MASI) score: The patient's face is divided into four parts: forehead, right forehead, left zygomatic bone, and chin. The area proportion, color depth, and uniformity of melasma in each part are evaluated before and after treatment. The corresponding score is 0 to 16 points. The lower the score, the milder the condition.
[0135] Statistical methods: SPSS 24.0 was used for statistical analysis. Count data were described using [cases (%)]; measurement data were described using ( ±s) and t-test was performed. P The difference was statistically significant when the value was less than 0.05.
[0136] Table 6 Comparison of the efficacy of freeze-dried group and postbiotic group [cases (%)]
[0137]
[0138] The results showed that after the Lactobacillus plantarum LZ015 freeze-dried powder group and the Lactobacillus plantarum LZ015 postbiotic group were tested, the efficacy level was statistically significant ( P <0.05), the total effective rate of Lactobacillus plantarum LZ015 freeze-dried powder group was 84.21%, and the total effective rate of Lactobacillus plantarum LZ015 postbiotic group was 89.47%. Both of them had a good effect on the regression and lightening of melasma. Lactobacillus plantarum LZ015 postbiotic was prepared by fermentation based on Pueraria root, and the effect was slightly better than that of Lactobacillus plantarum LZ015 freeze-dried powder.
[0139] Table 7 Comparison of MASI scores between the freeze-dried group and the postbiotic group before and after the trial ( ±s, minutes)
[0140]
[0141] Note: * indicates comparison with the same group before the trial. P <0.05.
[0142] The results showed that in the MASI score, the MASI scores of the Lactobacillus plantarum LZ015 freeze-dried powder group and the Lactobacillus plantarum LZ015 postbiotic group after treatment were significantly lower than those before the trial ( P<0.05); after the trial, there was no significant difference between the Lactobacillus plantarum LZ015 postbiotic group and the Lactobacillus plantarum LZ015 freeze-dried powder group, but the MASI score showed that the Lactobacillus plantarum LZ015 postbiotic group had a slightly better effect.
[0143] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A plant lactobacillus ( Lactiplantibacillus plantarum )LZ015, characterized in that, The deposit number of the Lactobacillus plantarum LZ015 is CGMCC No: 29395.
2. A method for preparing a freeze-dried powder of Lactobacillus plantarum LZ015, characterized in that: The method comprises the following steps: fermenting and culturing the plant lactobacillus LZ015 according to claim 1, centrifuging the fermentation liquid, adding a freeze-drying protective agent to the precipitate, and freeze-drying to obtain the plant lactobacillus LZ015 freeze-dried powder.
3. The preparation method according to claim 2, characterized in that: In terms of mass percentage, the lyophilization protective agent includes 8-12% skim milk, 7-9% trehalose, 4-6% sucrose, 5-7% maltodextrin, 1-3% mannose, 0.1-0.3% citric acid, 0.04-0.06% L-cysteine hydrochloride and 0.05-0.15% Tween 80.
4. The freeze-dried powder of Lactobacillus plantarum LZ015 prepared by the preparation method according to any one of claims 2 to 3.
5. A method for preparing a postbiotic of Lactobacillus plantarum LZ015, characterized in that: The method comprises the following steps: inoculating the Lactobacillus plantarum LZ015 described in claim 1 into kudzu root juice for fermentation and culturing, freeze-drying the kudzu root fermentation liquid, and obtaining the Lactobacillus plantarum LZ015 postbiotics.
6. The preparation method according to claim 5, characterized in that: In terms of mass percentage, the kudzu root juice also contains 8-12% glucose, 0.05-0.15% dipotassium hydrogen phosphate, 0.005-0.015% magnesium sulfate and 0.01-0.03% sodium acetate.
7. The preparation method according to claim 5, characterized in that: The pH value of the Pueraria juice is 6.5-7.
8. The Lactobacillus plantarum LZ015 postbiotic prepared by the preparation method according to any one of claims 5 to 7.
9. Use of the Lactobacillus plantarum LZ015 of claim 1 or the Lactobacillus plantarum LZ015 freeze-dried powder of claim 4 or the Lactobacillus plantarum LZ015 postbiotics of claim 8 in preparing a product for fading or lightening chloasma.
Citation Information
Patent Citations
Lactobacillus plantarum fermentation liquor, fermentation lysate as well as preparation method and application of lactobacillus plantarum fermentation liquor and fermentation lysate
CN116083283A
Lactic acid bacteria with skin cell repairing capability and application of lactic acid bacteria in cosmetics
CN118028139A
